Cargando…

EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma

OBJECTIVE: In this study, we aim to establish a non-invasive tool to predict epidermal growth factor receptor (EGFR) mutation status and subtypes based on radiomic features of computed tomography (CT). METHODS: A total of 233 lung adenocarcinoma patients were investigated and randomly divided into t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Quan, Li, Yan, Cheng, Qiguang, Van Valkenburgh, Juno, Sun, Xiaotian, Zheng, Chuansheng, Zhang, Ruiguang, Yuan, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165655/ https://www.ncbi.nlm.nih.gov/pubmed/35669165 http://dx.doi.org/10.2147/OTT.S352619

Ejemplares similares

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
por: Mei, Dongdong, et al.
Publicado: (2018)

Application of CT radiomics features to predict the EGFR mutation status and therapeutic sensitivity to TKIs of advanced lung adenocarcinoma
por: Yang, Chunsheng, et al.
Publicado: (2020)

Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma
por: Zhang, Baihua, et al.
Publicado: (2021)

Development of a Nomogram Based on 3D CT Radiomics Signature to Predict the Mutation Status of EGFR Molecular Subtypes in Lung Adenocarcinoma: A Multicenter Study
por: Zhang, Guojin, et al.
Publicado: (2022)

The predictive value of [(18)F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features
por: Huang, Weicheng, et al.
Publicado: (2022)

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
por: Digumarthy, Subba R., et al.
Publicado: (2019)

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors
por: Kim, Hyungjin, et al.
Publicado: (2017)

Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2021)

CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma
por: Shen, Tong-xu, et al.
Publicado: (2019)

Optimal (18)F-FDG PET/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study
por: Zuo, Yan, et al.
Publicado: (2023)

Pre-operative Prediction of Ki-67 Expression in Various Histological Subtypes of Lung Adenocarcinoma Based on CT Radiomic Features
por: Huang, Zhiwei, et al.
Publicado: (2021)

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
por: Zhang, Ruiguang, et al.
Publicado: (2016)

Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma
por: Hong, Duo, et al.
Publicado: (2020)

Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
por: Zhang, Guojin, et al.
Publicado: (2020)

Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma
por: Huo, Ji-wen, et al.
Publicado: (2022)

EGFR unusual mutation status in lung adenocarcinomas
por: Alarcão, Ana, et al.
Publicado: (2010)

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs
por: Yang, Liping, et al.
Publicado: (2022)

Differentiating synchronous double primary lung adenocarcinomas from intrapulmonary metastasis by CT features, EGFR mutations and ALK rearrangement status
por: Han, Xiaoyu, et al.
Publicado: (2020)

CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas
por: Han, Xiaoyu, et al.
Publicado: (2020)

Detection of EGFR mutations in early-stage lung adenocarcinoma by machine learning-based radiomics
por: Omura, Kenshiro, et al.
Publicado: (2023)

CT Radiomics Combined With Clinicopathological Features to Predict Invasive Mucinous Adenocarcinoma in Patients With Lung Adenocarcinoma
por: Zhang, Junjie, et al.
Publicado: (2023)

Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
por: Zheng, Lie, et al.
Publicado: (2022)

The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma
por: Zhao, Wei, et al.
Publicado: (2020)

Incorporating radiomic feature of pretreatment (18)F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma
por: Chen, Yu-Hung, et al.
Publicado: (2020)

Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis
por: Yao, Guangyu, et al.
Publicado: (2020)

Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma
por: Isaka, Tetsuya, et al.
Publicado: (2015)

Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer
por: Yamazaki, Motohiko, et al.
Publicado: (2022)

Radiomics Features of the Spleen as Surrogates for CT-Based Lymphoma Diagnosis and Subtype Differentiation
por: Enke, Johanna S., et al.
Publicado: (2022)

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Khalvati, Farzad, et al.
Publicado: (2019)

Diagnostic Efficacy of CT Radiomic Features in Pulmonary Invasive Mucinous Adenocarcinoma
por: Sheng, Aizhu, et al.
Publicado: (2022)

CT radiomic features of photodynamic priming in clinical pancreatic adenocarcinoma treatment
por: Vincent, Phuong, et al.
Publicado: (2021)

Preoperative (18)F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma
por: Choi, Wookjin, et al.
Publicado: (2023)

Performance of (18)F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
por: Zhang, Min, et al.
Publicado: (2020)

Association Analysis of Maximum Standardized Uptake Values Based on (18)F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma
por: Li, Xiumei, et al.
Publicado: (2023)

Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients—a radiomics nomogram analysis
por: Yang, Xiaoyan, et al.
Publicado: (2021)

Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients
por: Song, Lan, et al.
Publicado: (2020)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vckqngcuu4td5r5qfc7333relk